$SGEN News Article - Astellas and Seattle Genetics
Post# of 74
(Total Views: 385)
Posted On: 06/03/2019 12:15:40 PM
$SGEN News Article - Astellas and Seattle Genetics Announce Antibody-Drug Conjugate Enfortumab Vedotin Produced Tumor Response Rate of 44 Percent in Patients with Most Common Type of Advanced Urothelial (Bladder) Cancer https://marketwirenews.com/news-releases/aste...88380.html
(0)
(0)Seattle Genetics Inc. (SGEN) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼